Ross Wagner PharmD, BCPS, Ruchira Mahashabde MS, Jacob Painter PharmD, MBA, PhD, Kaci Boehmer PharmD, BCACP
{"title":"服用二甲双胍的 2 型糖尿病患者维生素 B12 缺乏风险增加的相关因素","authors":"Ross Wagner PharmD, BCPS, Ruchira Mahashabde MS, Jacob Painter PharmD, MBA, PhD, Kaci Boehmer PharmD, BCACP","doi":"10.1002/jppr.1913","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Metformin is used to treat type 2 diabetes mellitus, but prolonged use has been associated with vitamin B<sub>12</sub> deficiency. Many other factors have also been associated with vitamin B<sub>12</sub> deficiency. Studies on the possible additive effect of risk factors for developing a vitamin B<sub>12</sub> deficiency are lacking.</p>\n </section>\n \n <section>\n \n <h3> Aim</h3>\n \n <p>The objective of this study was to assess the correlation between other known risk factors for vitamin B<sub>12</sub> deficiency among patients with type 2 diabetes mellitus prescribed metformin who had a vitamin B<sub>12</sub> deficiency.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>For inclusion in this single-centre, retrospective cohort study, patients needed to be at least 18 years old, diagnosed with type 2 diabetes, taking metformin for at least 2 years and actively taking metformin during the study period. The primary outcome was the rate of low B<sub>12</sub> levels with metformin. Secondary outcomes were risk factors associated with B<sub>12</sub> deficiency. The patient and clinical characteristics were compared between the two study groups using Student's t-test for continuous variables and chi-squared tests for categorical variables. This project was exempt due to the local policy requirements that constitute research by the University of Arkansas for Medical Sciences Institutional Review Board (IRB) (IRB Program Manager, 11 August 2021). The justification for this ethics exemption was as follows: the project was determined to be of minimal risk to privacy of subjects because the research team had mechanisms to protect the personal health identifiers from improper use or disclosure; to destroy the identifiers at the earliest opportunity consistent with the conduct of research, and provided assurance that the identifiers will not be re-used or disclosed to any other person or entity, except as required by law, for authorised oversight of the research project, or for other research as permitted by the HIPAA regulations.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 387 patients were included in this study, from which 364 patients had a vitamin B<sub>12</sub> deficiency. The cohort was an average 69-years-old and predominantly female (66%). No risk factors were associated with a higher incidence of B<sub>12</sub> deficiency. Patient age (p = 0.0063) and time on metformin (p = 0.0144) were significantly and negatively correlated with B12 deficiency.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Younger age and shorter duration of metformin use may increase the risk of vitamin B<sub>12</sub> deficiency. Although guidelines recommend occasional checks, only 21% of patients had vitamin B<sub>12</sub> levels assessed during the study period.</p>\n </section>\n </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"54 3","pages":"236-241"},"PeriodicalIF":1.0000,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Factors associated with an increased risk of vitamin B12 deficiency in patients with type 2 diabetes mellitus on metformin\",\"authors\":\"Ross Wagner PharmD, BCPS, Ruchira Mahashabde MS, Jacob Painter PharmD, MBA, PhD, Kaci Boehmer PharmD, BCACP\",\"doi\":\"10.1002/jppr.1913\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Metformin is used to treat type 2 diabetes mellitus, but prolonged use has been associated with vitamin B<sub>12</sub> deficiency. Many other factors have also been associated with vitamin B<sub>12</sub> deficiency. Studies on the possible additive effect of risk factors for developing a vitamin B<sub>12</sub> deficiency are lacking.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Aim</h3>\\n \\n <p>The objective of this study was to assess the correlation between other known risk factors for vitamin B<sub>12</sub> deficiency among patients with type 2 diabetes mellitus prescribed metformin who had a vitamin B<sub>12</sub> deficiency.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Method</h3>\\n \\n <p>For inclusion in this single-centre, retrospective cohort study, patients needed to be at least 18 years old, diagnosed with type 2 diabetes, taking metformin for at least 2 years and actively taking metformin during the study period. The primary outcome was the rate of low B<sub>12</sub> levels with metformin. Secondary outcomes were risk factors associated with B<sub>12</sub> deficiency. The patient and clinical characteristics were compared between the two study groups using Student's t-test for continuous variables and chi-squared tests for categorical variables. This project was exempt due to the local policy requirements that constitute research by the University of Arkansas for Medical Sciences Institutional Review Board (IRB) (IRB Program Manager, 11 August 2021). The justification for this ethics exemption was as follows: the project was determined to be of minimal risk to privacy of subjects because the research team had mechanisms to protect the personal health identifiers from improper use or disclosure; to destroy the identifiers at the earliest opportunity consistent with the conduct of research, and provided assurance that the identifiers will not be re-used or disclosed to any other person or entity, except as required by law, for authorised oversight of the research project, or for other research as permitted by the HIPAA regulations.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>A total of 387 patients were included in this study, from which 364 patients had a vitamin B<sub>12</sub> deficiency. The cohort was an average 69-years-old and predominantly female (66%). No risk factors were associated with a higher incidence of B<sub>12</sub> deficiency. Patient age (p = 0.0063) and time on metformin (p = 0.0144) were significantly and negatively correlated with B12 deficiency.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Younger age and shorter duration of metformin use may increase the risk of vitamin B<sub>12</sub> deficiency. Although guidelines recommend occasional checks, only 21% of patients had vitamin B<sub>12</sub> levels assessed during the study period.</p>\\n </section>\\n </div>\",\"PeriodicalId\":16795,\"journal\":{\"name\":\"Journal of Pharmacy Practice and Research\",\"volume\":\"54 3\",\"pages\":\"236-241\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2024-03-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacy Practice and Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jppr.1913\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Practice and Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jppr.1913","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Factors associated with an increased risk of vitamin B12 deficiency in patients with type 2 diabetes mellitus on metformin
Background
Metformin is used to treat type 2 diabetes mellitus, but prolonged use has been associated with vitamin B12 deficiency. Many other factors have also been associated with vitamin B12 deficiency. Studies on the possible additive effect of risk factors for developing a vitamin B12 deficiency are lacking.
Aim
The objective of this study was to assess the correlation between other known risk factors for vitamin B12 deficiency among patients with type 2 diabetes mellitus prescribed metformin who had a vitamin B12 deficiency.
Method
For inclusion in this single-centre, retrospective cohort study, patients needed to be at least 18 years old, diagnosed with type 2 diabetes, taking metformin for at least 2 years and actively taking metformin during the study period. The primary outcome was the rate of low B12 levels with metformin. Secondary outcomes were risk factors associated with B12 deficiency. The patient and clinical characteristics were compared between the two study groups using Student's t-test for continuous variables and chi-squared tests for categorical variables. This project was exempt due to the local policy requirements that constitute research by the University of Arkansas for Medical Sciences Institutional Review Board (IRB) (IRB Program Manager, 11 August 2021). The justification for this ethics exemption was as follows: the project was determined to be of minimal risk to privacy of subjects because the research team had mechanisms to protect the personal health identifiers from improper use or disclosure; to destroy the identifiers at the earliest opportunity consistent with the conduct of research, and provided assurance that the identifiers will not be re-used or disclosed to any other person or entity, except as required by law, for authorised oversight of the research project, or for other research as permitted by the HIPAA regulations.
Results
A total of 387 patients were included in this study, from which 364 patients had a vitamin B12 deficiency. The cohort was an average 69-years-old and predominantly female (66%). No risk factors were associated with a higher incidence of B12 deficiency. Patient age (p = 0.0063) and time on metformin (p = 0.0144) were significantly and negatively correlated with B12 deficiency.
Conclusion
Younger age and shorter duration of metformin use may increase the risk of vitamin B12 deficiency. Although guidelines recommend occasional checks, only 21% of patients had vitamin B12 levels assessed during the study period.
期刊介绍:
The purpose of this document is to describe the structure, function and operations of the Journal of Pharmacy Practice and Research, the official journal of the Society of Hospital Pharmacists of Australia (SHPA). It is owned, published by and copyrighted to SHPA. However, the Journal is to some extent unique within SHPA in that it ‘…has complete editorial freedom in terms of content and is not under the direction of the Society or its Council in such matters…’. This statement, originally based on a Role Statement for the Editor-in-Chief 1993, is also based on the definition of ‘editorial independence’ from the World Association of Medical Editors and adopted by the International Committee of Medical Journal Editors.